Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Hess

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|September 4, 2012
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancerLisa M Hess, Frederick B Stehman, Michael W Method, et al.
Acta Haematologica|May 20, 2024
Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USADebora S Bruno, Manoj Khanal, Xiaohong I Li, et al.
Journal of Medical Economics|August 29, 2025
Continuity of care for patients with chronic lymphocytic leukemia: an analysis of real-world dataSameh Gabella, Manoj Khanal, Yongmei Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2008
Limits of detection of chemopreventive efficacy: karyometry of skin biopsiesPeter H Bartels, Michael L Yozwiak, Hubert G Bartels, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 7, 2019
Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaAfsaneh Barzi, Lisa M Hess, Yajun E Zhu, et al.
Journal of Patient-Reported Outcomes|January 22, 2024
Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item libraryJessica T Markowitz, Flora Mazerolle, Teya Lovell, et al.
Journal of Drug Assessment|January 6, 2021
The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancerLisa M Hess, David Smith, Zhanglin L Cui, et al.
JMIR Research Protocols|October 13, 2017
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study ProtocolLisa M Hess, David M Kern, Gebra Cuyun Carter, et al.
JMIR Cancer|April 12, 2021
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative ExplorationMichael Grabner, Cliff Molife, Liya Wang, et al.
Journal of Medical Economics|October 10, 2019
Value of clinical trial narrative data to estimate the costs of adverse event management: a feasibility studyDeirdre Mladsi, Lisa M Hess, Christine L Barnett, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|September 4, 2012
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancerLisa M Hess, Frederick B Stehman, Michael W Method, et al.
Acta Haematologica|May 20, 2024
Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USADebora S Bruno, Manoj Khanal, Xiaohong I Li, et al.
Journal of Medical Economics|August 29, 2025
Continuity of care for patients with chronic lymphocytic leukemia: an analysis of real-world dataSameh Gabella, Manoj Khanal, Yongmei Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2008
Limits of detection of chemopreventive efficacy: karyometry of skin biopsiesPeter H Bartels, Michael L Yozwiak, Hubert G Bartels, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 7, 2019
Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaAfsaneh Barzi, Lisa M Hess, Yajun E Zhu, et al.
Journal of Patient-Reported Outcomes|January 22, 2024
Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item libraryJessica T Markowitz, Flora Mazerolle, Teya Lovell, et al.
Journal of Drug Assessment|January 6, 2021
The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancerLisa M Hess, David Smith, Zhanglin L Cui, et al.
JMIR Research Protocols|October 13, 2017
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study ProtocolLisa M Hess, David M Kern, Gebra Cuyun Carter, et al.
JMIR Cancer|April 12, 2021
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative ExplorationMichael Grabner, Cliff Molife, Liya Wang, et al.
Journal of Medical Economics|October 10, 2019
Value of clinical trial narrative data to estimate the costs of adverse event management: a feasibility studyDeirdre Mladsi, Lisa M Hess, Christine L Barnett, et al.
Pageof 11